List of Tables
Table 1. Global Capecitabine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Capecitabine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Capecitabine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Capecitabine Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Capecitabine Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Capecitabine Tablets Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Capecitabine Tablets Sales by Region (2020-2025) & (K Units)
Table 8. Global Capecitabine Tablets Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Capecitabine Tablets Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Capecitabine Tablets Sales Share by Manufacturers (2020-2025)
Table 12. Global Capecitabine Tablets Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Capecitabine Tablets Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Capecitabine Tablets by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Capecitabine Tablets as of 2024)
Table 16. Global Capecitabine Tablets Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Capecitabine Tablets Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Capecitabine Tablets Manufacturing Base and Headquarters
Table 19. Global Capecitabine Tablets Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Capecitabine Tablets Sales by Type (2020-2025) & (K Units)
Table 23. Global Capecitabine Tablets Sales by Type (2026-2031) & (K Units)
Table 24. Global Capecitabine Tablets Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Capecitabine Tablets Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Capecitabine Tablets ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Capecitabine Tablets Sales by Application (2020-2025) & (K Units)
Table 29. Global Capecitabine Tablets Sales by Application (2026-2031) & (K Units)
Table 30. Capecitabine Tablets High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Capecitabine Tablets Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Capecitabine Tablets Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Capecitabine Tablets ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Capecitabine Tablets Growth Accelerators and Market Barriers
Table 37. North America Capecitabine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Capecitabine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Capecitabine Tablets Growth Accelerators and Market Barriers
Table 40. Europe Capecitabine Tablets Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Capecitabine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Capecitabine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Capecitabine Tablets Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Capecitabine Tablets Growth Accelerators and Market Barriers
Table 45. Southeast Asia Capecitabine Tablets Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Capecitabine Tablets Investment Opportunities and Key Challenges
Table 47. Central and South America Capecitabine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Capecitabine Tablets Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Capecitabine Tablets Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Roche Corporation Information
Table 51. Roche Description and Major Businesses
Table 52. Roche Product Models, Descriptions and Specifications
Table 53. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Roche Sales Value Proportion by Product in 2024
Table 55. Roche Sales Value Proportion by Application in 2024
Table 56. Roche Sales Value Proportion by Geographic Area in 2024
Table 57. Roche Capecitabine Tablets SWOT Analysis
Table 58. Roche Recent Developments
Table 59. Teva Pharmaceutical Corporation Information
Table 60. Teva Pharmaceutical Description and Major Businesses
Table 61. Teva Pharmaceutical Product Models, Descriptions and Specifications
Table 62. Teva Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Teva Pharmaceutical Sales Value Proportion by Product in 2024
Table 64. Teva Pharmaceutical Sales Value Proportion by Application in 2024
Table 65. Teva Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 66. Teva Pharmaceutical Capecitabine Tablets SWOT Analysis
Table 67. Teva Pharmaceutical Recent Developments
Table 68. Accord Healthcare Corporation Information
Table 69. Accord Healthcare Description and Major Businesses
Table 70. Accord Healthcare Product Models, Descriptions and Specifications
Table 71. Accord Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Accord Healthcare Sales Value Proportion by Product in 2024
Table 73. Accord Healthcare Sales Value Proportion by Application in 2024
Table 74. Accord Healthcare Sales Value Proportion by Geographic Area in 2024
Table 75. Accord Healthcare Capecitabine Tablets SWOT Analysis
Table 76. Accord Healthcare Recent Developments
Table 77. Dr. Reddy's Laboratories Corporation Information
Table 78. Dr. Reddy's Laboratories Description and Major Businesses
Table 79. Dr. Reddy's Laboratories Product Models, Descriptions and Specifications
Table 80. Dr. Reddy's Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Dr. Reddy's Laboratories Sales Value Proportion by Product in 2024
Table 82. Dr. Reddy's Laboratories Sales Value Proportion by Application in 2024
Table 83. Dr. Reddy's Laboratories Sales Value Proportion by Geographic Area in 2024
Table 84. Dr. Reddy's Laboratories Capecitabine Tablets SWOT Analysis
Table 85. Dr. Reddy's Laboratories Recent Developments
Table 86. Eugia Pharma Corporation Information
Table 87. Eugia Pharma Description and Major Businesses
Table 88. Eugia Pharma Product Models, Descriptions and Specifications
Table 89. Eugia Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Eugia Pharma Sales Value Proportion by Product in 2024
Table 91. Eugia Pharma Sales Value Proportion by Application in 2024
Table 92. Eugia Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Eugia Pharma Capecitabine Tablets SWOT Analysis
Table 94. Eugia Pharma Recent Developments
Table 95. Sun Pharma Corporation Information
Table 96. Sun Pharma Description and Major Businesses
Table 97. Sun Pharma Product Models, Descriptions and Specifications
Table 98. Sun Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Sun Pharma Recent Developments
Table 100. Qilu Pharmaceutical Corporation Information
Table 101. Qilu Pharmaceutical Description and Major Businesses
Table 102. Qilu Pharmaceutical Product Models, Descriptions and Specifications
Table 103. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Qilu Pharmaceutical Recent Developments
Table 105. Chia Tai-Tianqing Pharmaceutical Corporation Information
Table 106. Chia Tai-Tianqing Pharmaceutical Description and Major Businesses
Table 107. Chia Tai-Tianqing Pharmaceutical Product Models, Descriptions and Specifications
Table 108. Chia Tai-Tianqing Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Chia Tai-Tianqing Pharmaceutical Recent Developments
Table 110. Shanghai Sine Pharmaceutical Corporation Information
Table 111. Shanghai Sine Pharmaceutical Description and Major Businesses
Table 112. Shanghai Sine Pharmaceutical Product Models, Descriptions and Specifications
Table 113. Shanghai Sine Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Shanghai Sine Pharmaceutical Recent Developments
Table 115. Chengdu Easton Biopharmaceuticals Corporation Information
Table 116. Chengdu Easton Biopharmaceuticals Description and Major Businesses
Table 117. Chengdu Easton Biopharmaceuticals Product Models, Descriptions and Specifications
Table 118. Chengdu Easton Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Chengdu Easton Biopharmaceuticals Recent Developments
Table 120. Shandong New Time Pharmaceutical Corporation Information
Table 121. Shandong New Time Pharmaceutical Description and Major Businesses
Table 122. Shandong New Time Pharmaceutical Product Models, Descriptions and Specifications
Table 123. Shandong New Time Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Shandong New Time Pharmaceutical Recent Developments
Table 125. Key Raw Materials Distribution
Table 126. Raw Materials Key Suppliers
Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 128. Milestones in Production Technology Evolution
Table 129. Distributors List
Table 130. Market Trends and Market Evolution
Table 131. Market Drivers and Opportunities
Table 132. Market Challenges, Risks, and Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Capecitabine Tablets Product Picture
Figure 2. Global Capecitabine Tablets Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 150mg Product Picture
Figure 4. 500mg Product Picture
Figure 5. Global Capecitabine Tablets Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Colon Cancer
Figure 7. Breast Cancer
Figure 8. Stomach Cancer
Figure 9. Capecitabine Tablets Report Years Considered
Figure 10. Global Capecitabine Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 12. Global Capecitabine Tablets Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Capecitabine Tablets Revenue Market Share by Region (2020-2031)
Figure 14. Global Capecitabine Tablets Sales (2020-2031) & (K Units)
Figure 15. Global Capecitabine Tablets Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Capecitabine Tablets Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Capecitabine Tablets Sales Volume Market Share in 2024
Figure 18. Global Capecitabine Tablets Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. 150mg Revenue Market Share by Manufacturer in 2024
Figure 21. 500mg Revenue Market Share by Manufacturer in 2024
Figure 22. Global Capecitabine Tablets Sales Market Share by Type (2020-2031)
Figure 23. Global Capecitabine Tablets Revenue Market Share by Type (2020-2031)
Figure 24. Global Capecitabine Tablets Sales Market Share by Application (2020-2031)
Figure 25. Global Capecitabine Tablets Revenue Market Share by Application (2020-2031)
Figure 26. North America Capecitabine Tablets Sales YoY (2020-2031) & (K Units)
Figure 27. North America Capecitabine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Capecitabine Tablets Sales Revenue (US$ Million) in 2024
Figure 29. North America Capecitabine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Capecitabine Tablets Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Capecitabine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Capecitabine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Capecitabine Tablets Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Capecitabine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Capecitabine Tablets Sales Revenue (US$ Million) in 2024
Figure 39. Europe Capecitabine Tablets Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Capecitabine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Capecitabine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Capecitabine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 44. France Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Capecitabine Tablets Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Capecitabine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Capecitabine Tablets Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Capecitabine Tablets Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Capecitabine Tablets Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Capecitabine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Capecitabine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 59. India Capecitabine Tablets Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Capecitabine Tablets Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Capecitabine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Capecitabine Tablets Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Capecitabine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Capecitabine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Capecitabine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Capecitabine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Capecitabine Tablets Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Capecitabine Tablets Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Capecitabine Tablets Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Capecitabine Tablets Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Capecitabine Tablets Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Capecitabine Tablets Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Capecitabine Tablets Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Capecitabine Tablets Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Capecitabine Tablets Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Capecitabine Tablets Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Capecitabine Tablets Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Capecitabine Tablets Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Capecitabine Tablets Revenue (2020-2025) & (US$ Million)
Figure 80. Capecitabine Tablets Industry Chain Mapping
Figure 81. Regional Capecitabine Tablets Manufacturing Base Distribution (%)
Figure 82. Global Capecitabine Tablets Production Market Share by Region (2020-2031)
Figure 83. Capecitabine Tablets Production Process
Figure 84. Regional Capecitabine Tablets Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
